HIV and STI Prevalence and Injection Behaviors Among People Who Inject Drugs in Nairobi: Results from a 2011 Bio-behavioral Study Using Respondent-Driven Sampling

Tun, Waimar; Sheehy, Meredith; Broz, Dita; Okal, Jerry; Muraguri, Nicholas; Raymond, H. Fisher; Musyoki, Helgar; Kim, Andrea A.; Muthui, Mercy; Geibel, Scott

doi:10.1007/s10461-014-0936-3

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

HIV and STI Prevalence and Injection Behaviors Among People Who Inject Drugs in Nairobi: Results from a 2011 Bio-behavioral Study Using Respondent-Driven Sampling

Published Date:

Feb 2015

Publisher's site:

http://dx.doi.org/10.1007/s10461-014-0936-3

Source:

AIDS Behav. 19(Suppl 1):24-35.

Series:

PEPFAR

Language:

English

[PDF-364.37 KB]

Details:

Alternative Title:

AIDS Behav

Personal Author:

Tun, Waimar ; Sheehy, Meredith ; Broz, Dita ; Okal, Jerry ; Muraguri, Nicholas ; ... More ▼

Description:

There is a dearth of evidence on injection drug use and associated HIV infections in Kenya. To generate population-based estimates of characteristics and HIV/STI prevalence among people who inject drugs (PWID) in Nairobi, a cross-sectional study was conducted with 269 PWID using respondent-driven sampling. PWID were predominantly male (92.5 %). An estimated 67.3 % engaged in at least one risky injection practice in a typical month. HIV prevalence was 18.7 % (95 % CI 12.3-26.7), while STI prevalence was lower [syphilis: 1.7 % (95 % CI 0.2-6.0); gonorrhea: 1.5 % (95 % CI 0.1-4.9); and Chlamydia: 4.2 % (95 % CI 1.2-7.8)]. HIV infection was associated with being female (aOR, 3.5; p = 0.048), having first injected drugs 5 or more years ago (aOR, 4.3; p = 0.002), and ever having practiced receptive syringe sharing (aOR, 6.2; p = 0.001). Comprehensive harm reduction programs tailored toward PWID and their sex partners must be fully implemented as part of Kenya's national HIV prevention strategy.

Subject:

[+]

Pubmed ID:

25398417

Pubmed Central ID:

PMC4352193

Document Type:

Journal Article

Funding:

U62 PS224506/PS/NCHHSTP CDC HHS/United States ; 5U62PS224506/PS/NCHHSTP CDC HHS/United States ; PEPFAR/United States ;

Place as Subject:

Kenya

Collection(s):

CDC Public Access

Main Document Checksum:

[+]

Supporting Files:

	10461_2014_936_Fig1_HTML.gif	image/gif
	10461_2014_936_Fig1_HTML.jpg	image/jpeg
	10461_2014_Article_936.nxml	application/octet-stream

No Related Documents.

You May Also Like:

COVID-19 mitigation behaviors by age group — United States, April–June 2020

Personal Author:

Hutchins, Helena J.; Wolff, Brent; Leeb, Rebecca; Ko, P Jean Y.; Odom, Erika; Willey, Joe; Friedman, Allison; Bitsko, Rebecca H.;

Corporate Authors:

CDC COVID-19 Response Team.. Data Foundation (Washington, DC). National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention). Division of Human Development and Disability..

Published Date:

October 27, 2020

Series:

MMWR. Morbidity and mortality weekly report ; v. 69, early release, October 27, 2020

Description:

What is already known about this topic? Recommended mitigation behaviors to prevent the spread of COVID-19 include wearing masks, hand washing, social distancing, and staying home when ill.What is added by this report? Self-reported engagement in mit...

File Type:

[PDF - 206.47 KB]
COVID-19 outbreak among a university’s men’s and women’s soccer teams — Chicago, Illinois, July–August 2020

Personal Author:

Teran, Richard A.; Ghinai, Isaac; Gretsch, Stephanie; Cable, Tracy; Black, Stephanie R.; Green, Stefan J.; Perez, Omar; Chlipala, George E.; Maienschein-Cline, Mark; Kunstman, Kevin J.; Bleasdale, Susan C.; Fricchione, Marielle J.;

Corporate Authors:

Centers for Disease Control and Prevention (U.S.). Epidemic Intelligence Service.. Chicago (Ill.). Department of Public Health.. University of Illinois at Chicago..

Published Date:

October 27, 2020

Series:

MMWR. Morbidity and mortality weekly report ; v. 69, early release, October 27, 2020

Description:

What is already known about this topic? SARS-CoV-2 transmission occurs in congregate settings, including colleges and universities.What is added by this report? Investigation of 17 COVID-19 cases among a university’s men’s and women’s soccer te...

File Type:

[PDF - 192.87 KB]
Developing a wastewater surveillance sampling strategy

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Published Date:

October 23, 2020

Description:

Updated Oct. 23, 2020Use this guidance to implement wastewater-based disease surveillance. Wastewater-based disease surveillance is a rapidly developing science, and CDC will continue to update guidance and information as it becomes available.

File Type:

[PDF - 195.82 KB]
Wastewater surveillance testing methods

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Published Date:

October 23, 2020

Description:

Updated Oct. 23, 2020Use this guidance to implement wastewater-based disease surveillance. Wastewater-based disease surveillance is a rapidly developing science, and CDC will continue to update guidance and information as it becomes available.

File Type:

[PDF - 219.92 KB]
Targeted wastewater surveillance at facilities, institutions, and workplaces

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Published Date:

October 23, 2020

Description:

Updated Oct. 23, 2020Use this guidance to implement wastewater-based disease surveillance. Wastewater-based disease surveillance is a rapidly developing science, and CDC will continue to update guidance and information as it becomes available.

File Type:

[PDF - 179.13 KB]